Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Select Medical Hldgs Affirms FY2025 GAAP EPS Guidance of $1.09-$1.19 vs $1.42 Est; Lowers FY2025 Sales Guidance from $5.40B-$5.60B to $5.30B-$5.50B vs $5.47B Est

Author: Benzinga Newsdesk | May 01, 2025 04:22pm
Select Medical Hldgs (NYSE:SEM) affirms FY2025 GAAP EPS guidance from $1.09-$1.19 to $1.09-$1.19 vs $1.42 analyst estimate. Lowers FY2025 sales outlook from $5.40 billion-$5.60 billion to $5.30 billion-$5.50 billion vs $5.47 billion estimate.

Posted In: SEM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist